Israel Englander Illumina, Inc. Call Options Transaction History

Millennium Management LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$105.28 - $135.9 $2.19 Million - $2.83 Million	20,800 New	20,800 $2.71 Million
Q1 2024 May 15, 2024	SELL	$127.73 - $147.2 $523,693 - $603,520	-4,100 Reduced 7.17%	53,100 $7.29 Million
Q4 2023 Feb 14, 2024	SELL	$92.79 - $142.53 $10.1 Million - $15.5 Million	-108,500 Reduced 65.48%	57,200 $7.96 Million
Q2 2023 Aug 14, 2023	BUY	$183.43 - $232.67 $17.4 Million - $22.1 Million	94,900 Added 134.04%	165,700 $31.1 Million
Q1 2023 May 15, 2023	BUY	$193.75 - $232.55 $12.5 Million - $15 Million	64,400 Added 1006.25%	70,800 $16.5 Million
Q4 2022 Feb 14, 2023	BUY	$187.24 - $242.74 $636,616 - $825,316	3,400 Added 113.33%	6,400 $1.29 Million
Q3 2022 Nov 14, 2022	SELL	$177.23 - $227.44 $584,859 - $750,552	-3,300 Reduced 52.38%	3,000 $572,000

901

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $22.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.